Clinical Trial Update: Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial updating preoperative short-course radiation followed by Envafolimab + CAPEOX for locally advanced rectal adenocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• CAPEOX
• Envafolimab (envafolimab)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Rectal Cancer | Phase 3 | Status: RECRUITING